136 related articles for article (PubMed ID: 27739660)
1. The 88-kDa Eales' protein in serum is a complex of haptoglobin, complement C3, and galectin-1 as identified by liquid chromatography coupled mass spectrometry.
Ramanujam S; Muthuvel B; Aravind C B; Biswas J; Konerirajapuram NS
Proteomics Clin Appl; 2017 Jan; 11(1-2):. PubMed ID: 27739660
[TBL] [Abstract][Full Text] [Related]
2. Complement component C3: Serologic signature for osteogenesis imperfecta. Analysis of a comparative proteomic study.
Kuo SJ; Wang FS; Sheen JM; Yu HR; Wu SL; Ko JY
J Formos Med Assoc; 2015 Oct; 114(10):943-9. PubMed ID: 24612500
[TBL] [Abstract][Full Text] [Related]
3. Increased Toll-like receptor-2 expression on nonclassic CD16+ monocytes from patients with inflammatory stage of Eales' disease.
Sen A; Chowdhury IH; Mukhopadhyay D; Paine SK; Mukherjee A; Mondal LK; Chatterjee M; Bhattacharya B
Invest Ophthalmol Vis Sci; 2011 Sep; 52(9):6940-8. PubMed ID: 21791592
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of a novel 88 kDa protein from serum and vitreous of patients with Eales' disease.
Sulochana KN; Rajesh M; Ramakrishnan S
Exp Eye Res; 2001 Oct; 73(4):547-55. PubMed ID: 11825025
[TBL] [Abstract][Full Text] [Related]
5. Impact of interleukin-6 promoter polymorphism and serum interleukin-6 level on the acute inflammation and neovascularization stages of patients with Eales' disease.
Sen A; Paine SK; Chowdhury IH; Mukherjee A; Choudhuri S; Saha A; Mandal LK; Bhattacharya B
Mol Vis; 2011; 17():2552-63. PubMed ID: 22025890
[TBL] [Abstract][Full Text] [Related]
6. Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients.
Carlsson MC; Cederfur C; Schaar V; Balog CI; Lepur A; Touret F; Salomonsson E; Deelder AM; Fernö M; Olsson H; Wuhrer M; Leffler H
PLoS One; 2011; 6(10):e26560. PubMed ID: 22028908
[TBL] [Abstract][Full Text] [Related]
7. Elevated tumor necrosis factor in serum is associated with increased retinal ischemia in proliferative eales' disease.
Saxena S; Khanna VK; Pant AB; Meyer CH; Singh VK
Pathobiology; 2011; 78(5):261-5. PubMed ID: 21849807
[TBL] [Abstract][Full Text] [Related]
8. Involvement of oxidative and nitrosative stress in promoting retinal vasculitis in patients with Eales' disease.
Rajesh M; Sulochana KN; Punitham R; Biswas J; Lakshmi S; Ramakrishnan S
Clin Biochem; 2003 Jul; 36(5):377-85. PubMed ID: 12849870
[TBL] [Abstract][Full Text] [Related]
9. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
[TBL] [Abstract][Full Text] [Related]
10. Total antioxidant capacity in Eales' disease, uveitis & cataract.
Selvi R; Angayarkanni N; Biswas J; Ramakrishnan S
Indian J Med Res; 2011 Jul; 134(1):83-90. PubMed ID: 21808139
[TBL] [Abstract][Full Text] [Related]
11. Immunolocalization and quantification of advanced glycation end products in retinal neovascular membranes and serum: a possible role in ocular neovascularization.
Swamy-Mruthinti S; Miriam KC; Kumar SK; Biswas J; Ramakrishnan S; Nagaraj RH; Sulochana KN
Curr Eye Res; 2002 Sep; 25(3):139-45. PubMed ID: 12607183
[TBL] [Abstract][Full Text] [Related]
12. Assessment of gelatinase and tumor necrosis factor-α level in the vitreous and serum of patients with Eales disease: role of inflammation-mediated angiogenesis in the pathogenesis of Eales disease.
Sen A; Paine SK; Chowdhury IH; Mukherjee A; Choudhury S; Mandal LK; Bhattacharya B
Retina; 2011; 31(7):1412-20. PubMed ID: 21394064
[TBL] [Abstract][Full Text] [Related]
13. Determination of carbonyl group content in plasma proteins as a useful marker to assess impairment in antioxidant defense in patients with Eales' disease.
Rajesh M; Sulochana KN; Coral K; Punitham R; Biswas J; Babu K; Ramakrishnan S
Indian J Ophthalmol; 2004 Jun; 52(2):139-44. PubMed ID: 15283219
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of 8-hydroxydeoxyguanosine and its relationship with antioxidant parameters in patients with Eales' disease: implications for antioxidant therapy.
Rajesh M; Ramesh A; Ravi PE; Balakrishnamurthy P; Coral K; Punitham R; Sulochana KN; Biswas J; Ramakrishnan S
Curr Eye Res; 2003 Aug; 27(2):103-10. PubMed ID: 14632162
[TBL] [Abstract][Full Text] [Related]
15. Association of Mycobacterium tuberculosis in the causation of Eales' disease: an institutional experience.
; Singh UB; Mohapatra S; Wagh VK; Porwal C; Kaushik A
Indian J Med Microbiol; 2015 Feb; 33 Suppl():43-5. PubMed ID: 25657155
[TBL] [Abstract][Full Text] [Related]
16. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer.
Takahashi S; Sugiyama T; Shimomura M; Kamada Y; Fujita K; Nonomura N; Miyoshi E; Nakano M
Glycoconj J; 2016 Jun; 33(3):471-82. PubMed ID: 26869352
[TBL] [Abstract][Full Text] [Related]
17. A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer.
Bresalier RS; Byrd JC; Tessler D; Lebel J; Koomen J; Hawke D; Half E; Liu KF; Mazurek N;
Gastroenterology; 2004 Sep; 127(3):741-8. PubMed ID: 15362030
[TBL] [Abstract][Full Text] [Related]
18. Iron chelation abrogates excessive formation of hydroxyl radicals and lipid peroxidation products in monocytes of patients with Eales' disease: direct evidence using electron spin resonance spectroscopy.
Rajesh M; Sulochana KN; Ramakrishnan S; Biswas J; Manoharan PT
Curr Eye Res; 2004 Jun; 28(6):399-407. PubMed ID: 15512947
[TBL] [Abstract][Full Text] [Related]
19. N-glycosylation status of beta-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects.
Park SY; Yoon SJ; Jeong YT; Kim JM; Kim JY; Bernert B; Ullman T; Itzkowitz SH; Kim JH; Hakomori SI
Int J Cancer; 2010 Jan; 126(1):142-55. PubMed ID: 19551866
[TBL] [Abstract][Full Text] [Related]
20. Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers.
Nakano M; Nakagawa T; Ito T; Kitada T; Hijioka T; Kasahara A; Tajiri M; Wada Y; Taniguchi N; Miyoshi E
Int J Cancer; 2008 May; 122(10):2301-9. PubMed ID: 18214858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
